VIB Vermoegen AG
XBER:VIH1

Watchlist Manager
VIB Vermoegen AG Logo
VIB Vermoegen AG
XBER:VIH1
Watchlist
Price: 7.34 EUR 2.8% Market Closed
Market Cap: 865.5m EUR
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one VIH1 stock under the Base Case scenario is 36.55 EUR. Compared to the current market price of 7.34 EUR, VIB Vermoegen AG is Undervalued by 80%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

VIH1 Relative Value
Base Case
36.55 EUR
Undervaluation 80%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

2.3
P/S
P/S
Price to Sales
2.3
vs History
98
vs Industry
49
Median 3Y
3.7
Median 5Y
6.1
Industry
3.7
Forward
2
More Details
6.7
P/E
P/E
Price to Earnings
6.7
vs History
58
vs Industry
55
Median 3Y
4.3
Median 5Y
8.3
Industry
16.5
Forward
3.8
More Details
2.7
P/OCF
P/OCF
Price to OCF
2.7
vs History
95
vs Industry
56
Median 3Y
6.4
Median 5Y
9
Industry
11.1
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
1
Median 3Y
7.4
Median 5Y
10.9
Industry
13
More Details
0.3
P/B
P/B
Price to Book Value
0.3
vs History
96
vs Industry
73
Median 3Y
0.6
Median 5Y
1
Industry
0.9
More Details
8.8
EV/S
EV/S
Enterprise Value to Sales
8.8
vs History
88
vs Industry
23
Median 3Y
10.8
Median 5Y
12.2
Industry
6.6
Forward
7.5
More Details
11.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
11.2
vs History
88
vs Industry
33
Median 3Y
13
Median 5Y
14.8
Industry
12
More Details
4.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
4.3
vs History
98
vs Industry
42
Median 3Y
10.3
Median 5Y
17.9
Industry
15.8
Forward
10.5
More Details
12.6
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
12.6
vs History
88
vs Industry
27
Median 3Y
14.3
Median 5Y
19
Industry
18.9
Forward
16.5
More Details
10.1
EV/OCF
EV/OCF
Enterprise Value to OCF
10.1
vs History
98
vs Industry
40
Median 3Y
14.6
Median 5Y
17.4
Industry
18.5
More Details
10.1
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
10.1
vs History
92
vs Industry
36
Median 3Y
14.7
Median 5Y
16.5
Industry
20
More Details
0.5
EV/IC
EV/IC
Enterprise Value to IC
0.5
vs History
98
vs Industry
56
Median 3Y
0.7
Median 5Y
0.9
Industry
0.7
More Details

Multiples Across Competitors

VIH1 Competitors Multiples
VIB Vermoegen AG Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
DE
VIB Vermoegen AG
XBER:VIH1
242.6m EUR 2.3 6.7 4.3 12.6
DE
Vonovia SE
XETRA:VNA
23.7B EUR 4.5 -33.4 23 24.4
CN
Zhejiang China Commodities City Group Co Ltd
SSE:600415
96.6B CNY 6 30.5 24.2 24.2
HK
Swire Properties Ltd
HKEX:1972
100B HKD 6.9 -130.6 16.6 17.6
PH
SM Prime Holdings Inc
XPHS:SMPH
650.7B PHP 4.6 13.9 10.6 12.9
BM
Hongkong Land Holdings Ltd
SGX:H78
11.4B USD 5.7 -8.2 25.7 26.2
CH
Swiss Prime Site AG
SIX:SPSN
9B CHF 13.7 25.1 32.5 33.2
CN
China Resources Mixc Lifestyle Services Ltd
HKEX:1209
85.3B HKD 4.6 21.6 15.2 15.2
DE
Deutsche Wohnen SE
XETRA:DWNI
9.1B EUR 4.8 -15.4 16.4 17.1
SE
Sagax AB
STO:SAGA A
97.1B SEK 19 19.2 30.9 30.9
SG
Capitaland Investment Ltd
SGX:9CI
12.6B SGD 4.5 26.2 19 22.5
P/E Multiple
Earnings Growth PEG
DE
VIB Vermoegen AG
XBER:VIH1
Average P/E: 20.5
6.7
N/A N/A
DE
Vonovia SE
XETRA:VNA
Negative Multiple: -33.4 N/A N/A
CN
Zhejiang China Commodities City Group Co Ltd
SSE:600415
30.5
28%
1.1
HK
S
Swire Properties Ltd
HKEX:1972
Negative Multiple: -130.6 N/A N/A
PH
S
SM Prime Holdings Inc
XPHS:SMPH
13.9
8%
1.7
BM
Hongkong Land Holdings Ltd
SGX:H78
Negative Multiple: -8.2 N/A N/A
CH
Swiss Prime Site AG
SIX:SPSN
25.1
1%
25.1
CN
China Resources Mixc Lifestyle Services Ltd
HKEX:1209
21.6
15%
1.4
DE
Deutsche Wohnen SE
XETRA:DWNI
Negative Multiple: -15.4 N/A N/A
SE
S
Sagax AB
STO:SAGA A
19.2
6%
3.2
SG
Capitaland Investment Ltd
SGX:9CI
26.2
27%
1

See Also

Summary
VIH1 intrinsic value, competitors valuation, and company profile.
DCF Valuation
VIH1 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
VIH1 stock valuation using valuation multiples.
Wall Street Estimates
VIH1 price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
VIH1 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 258,600+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.